VASH1 and neoplasm: The interplay between VASH1 and VASH2 underscores their potential as prognostic biomarkers, with VASH1 levels in circulating white blood cells (WBCs) possibly indicating anti-angiogenic capacity, tumor behavior, and response to therapies.